Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms

被引:0
作者
Joonhong Park
Hoon Seok Kim
Jong-Mi Lee
Jin Jung
Dain Kang
Hayoung Choi
Gun Dong Lee
Jungok Son
Silvia Park
Byung‐Sik Cho
Hee‐Je Kim
Seongkoo Kim
Jae Wook Lee
Nack-Gyun Chung
Bin Cho
Hua Zhang
Nickolay A. Khazanov
Jongpill Choi
Jae-Won Jung
Yonggoo Kim
Myungshin Kim
机构
[1] The Catholic University of Korea,Department of Laboratory Medicine
[2] The Catholic University of Korea,Catholic Genetic Laboratory Center, Seoul St. Mary’s Hospital, College of Medicine
[3] The Catholic University of Korea,Division of Acute Leukemia, Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine
[4] The Catholic University of Korea,Department of Pediatrics, College of Medicine
[5] Thermo Fisher Scientific,undefined
[6] Thermo Fisher Scientific Solutions,undefined
来源
Molecular Diagnosis & Therapy | 2020年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:579 / 592
页数:13
相关论文
共 161 条
[1]  
Luthra R(2014)Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring Haematologica 99 465-473
[2]  
Patel KP(2018)Current status and trends in the diagnostics of AML and MDS Blood Rev 32 508-519
[3]  
Reddy NG(2018)Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use Blood Cancer J 8 113-240
[4]  
Haghshenas V(2019)Clinical utility of a next-generation sequencing panel for acute myeloid leukemia diagnostics J Mol Diagn 21 228-506
[5]  
Routbort MJ(2019)Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms PLoS ONE 14 e0212228-37
[6]  
Harmon MA(2019)Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms Cancers. 11 1-126
[7]  
Shumilov E(2019)Next generation sequencing in AML-on the way to becoming a new standard for treatment initiation and/or modulation? Cancers. 11 1-105
[8]  
Flach J(2016)Targeted next-generation sequencing in myelodysplastic syndrome and chronic myelomonocytic leukemia aids diagnosis in challenging cases and identifies frequent spliceosome mutations in transformed acute myeloid leukemia Am J Clin Pathol 145 497-503
[9]  
Kohlmann A(2017)Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing Eur J Haematol 98 26-461
[10]  
Banz Y(2018)Genetic landscape of acute myeloid leukemia interrogated by next-generation sequencing: a large cancer center experience Cancer Genomics Proteomics 15 121-20